Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents
| dc.contributor.author | Genc, Murat | |
| dc.contributor.author | Genc, Zuhal Karagoz | |
| dc.contributor.author | Tekin, Suat | |
| dc.contributor.author | Sandal, Suleyman | |
| dc.contributor.author | Sirajuddin, Muhammad | |
| dc.contributor.author | Ben Hadda, Taibi | |
| dc.contributor.author | Sekerci, Memet | |
| dc.date.accessioned | 2026-08-12T17:17:04Z | |
| dc.date.issued | 2016 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | This article demonstrates the synthesis of 1,2,4-triazole derivatives and their applications in medicine particularly as anti-breast cancer agents which is a major issue of the present. The synthesized compounds were characterized by elemental analysis, FT-IR and NMR. DFT was used to study the quantum chemical calculations of geometries and vibrational wave numbers of 3-hydroxynaphthyl and p-tolyl substituted 1,2,4-triazoles in the ground state. The scaled harmonic vibrational frequencies obtained from the DFT method were compared with those of the FT-IR spectra and found good agreement. The synthesized 1,2,4-triazole-naphthyl hybrids were screened for the anticancer activity against MCF-7 breast cancer lines. Among them compounds 3 and 7 showed broad spectrum anticancer activity with IC50 values 9.7 mu M and 7.10 mu M, respectively and their activity is comparable to that of the standard drugs. The molecular model for binding between the compounds (1-8) and the active site of BRCA2 was obtained on the basis of the computational docking results and the structure-activity relationship. | |
| dc.description.sponsorship | Adiyaman University Research Foundation [FEFAAP/2012-0001] | |
| dc.description.sponsorship | We are indebted to the Adiyaman University Research Foundation (FEFAAP/2012-0001) for financial support of this work. | |
| dc.identifier.doi | 10.17344/acsi.2016.2428 | |
| dc.identifier.endpage | 737 | |
| dc.identifier.issn | 1318-0207 | |
| dc.identifier.issn | 1580-3155 | |
| dc.identifier.issue | 4 | |
| dc.identifier.orcid | 0000-0002-5633-6203 | |
| dc.identifier.orcid | 0000-0003-1224-4128 | |
| dc.identifier.orcid | 0000-0002-2757-1802 | |
| dc.identifier.orcid | 0000-0002-1147-1284 | |
| dc.identifier.pmid | 28004087 | |
| dc.identifier.scopus | 2-s2.0-85004097356 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 726 | |
| dc.identifier.uri | https://doi.org/10.17344/acsi.2016.2428 | |
| dc.identifier.uri | https://hdl.handle.net/11508/52530 | |
| dc.identifier.volume | 63 | |
| dc.identifier.wos | WOS:000392743500006 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Slovensko Kemijsko Drustvo | |
| dc.relation.ispartof | Acta Chimica Slovenica | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | 1,2,4-triazoles | |
| dc.subject | Docking | |
| dc.subject | DFT | |
| dc.subject | POM Analysis | |
| dc.subject | Breast cancer | |
| dc.title | Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents | |
| dc.type | Article |







